Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
37 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Zealand Pharma A/S (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicinies that targets specialty diseases. The companys out-licensing medicines that include Lyxumia or lixisenatide for the treatment of Type 2 diabetes and others for the treatment of obesity and for chemotherapeutic use. Zealand also offers proprietary pipeline drug candidates for the treatment of diabetes, short bowel syndrome, obesity; severe and acute hypoglycemia and other indications. The company also offers research and development; in licensing and out licensing services.

Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of eac

  
Source:
Document ID
GDPH137093D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Zealand Pharma A/S, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Zealand Pharma A/S, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Zealand Pharma A/S, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Zealand Pharma A/S, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Zealand Pharma A/S, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Zealand Pharma A/S, Pharmaceuticals &Healthcare, Deal Details1123
  Partnerships111
    Zealand Pharma Partners with Beta Bionics111
    Zealand Pharma And Eli Lilly Enter Into Research Agreement For Obesity And Diabetes121
    Zealand Pharma And D. E. Shaw Research Enter Into Research Agreement For Peptide Drug Design131
    Zealand Pharma Enters into Co-Development Agreement with Protagonist Therapeutics for Peptide Drugs142
    Zealand Pharma Enters Into Agreement With Pepscan Holding161
    PolyTherics Enters Into Research Collaboration With Zealand Pharma171
  Licensing Agreements181
    Zealand Pharma Enters into Licensing Agreement with Boehringer182
    Zealand Pharma Enters Into Licensing Agreement With Abbott Labs For AP214201
    Zealand Pharma Enters Into Licensing And Collaboration Agreement With Boehringer Ingelheim212
    Serodus Enters into Licensing Agreement with Zealand Pharma for SER100231
    Zealand Pharma Extends Licensing Agreement With Sanofi-Aventis242
  Equity Offering261
    Zealand Pharma Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants261
    Zealand Pharma Raises USD0.67 Million in Private Placement of Shares upon Exercise of Warrants271
    Zealand Pharma Completes Private Placement Of Shares For US$1.5 Million281
    Zealand Pharma Raises US$4 Million Upon Exercise Of Warrants291
    Zealand Pharma Completes IPO For US$70 Million302
  Asset Transactions321
    Serodus Completes Acquisition Of ZP-120 From Zealand Pharma322
Zealand Pharma A/S - Key Competitors341
Key Employees351
Locations And Subsidiaries361
  Head Office361
Appendix371
  Methodology371
  About GlobalData371
  Contact Us371
  Disclaimer371

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zealand-Pharma-A-S-ZEAL-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10103>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Zealand Pharma A/S (ZEAL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Zealand-Pharma-A-S-ZEAL-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-10103>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research